AHA Scientific Sessions 2026 Abstract·Nov 9Weight-Loss-Enriched Reverse Cardiac Remodeling After Semaglutide and Tirzepatide Initiation on Longitudinal EchocardiographyCohort study of 3,500 peopleTirzepatidePaper
Advances in Pharmacology·Nov 4When to use first-generation anti-obesity medications: Mechanisms, clinical indications, and patient-focused selectionReviewObesityPaper
Diabetes, Metabolic Syndrome and Obesity·Nov 3Management of Obesity in Special Populations and Limited-Resource Settings: An Egyptian Medical Position StatementCommentaryIndustry & policyPaper
Pharmaceutics·Oct 27Progress in Anti-Obesity Drug Development: A Pharmacodynamics PerspectiveReviewObesityPaper
Drug Design, Development and Therapy·Oct 14Oral Obesity Medicines in the Era of Cardiovascular-Kidney-Metabolic Syndrome (CKM): Beyond Weight Loss Toward Disease ModificationReviewCardiovascular-kidney-metabolic syndromePaper
Diabetes, Metabolic Syndrome and Obesity·Oct 1Recent Studies on the Effectiveness and Safety of Anti-Obesity Medications: A Scoping ReviewSystematic review of studies in peopleObesityPaper
Indian Journal of Pharmacology·Sep 2Pharmacological management of obesity: Current landscape and emerging therapiesReviewObesityPaper
Diabetes, Obesity & Metabolism·Jun 9Risk of Age-Related Ocular Diseases in Non-Diabetic Adults With Obesity Using Glucagon-Like Peptide 1 Receptor AgonistsCohort study of 68,536 peopleObesityPaper
ADA Scientific Sessions 2026 Abstract·Jun 6Effect of Obesity Management Medications on Physical Function: A Systematic Review and Meta-analysisMeta-analysis of randomized trialsObesityPaper
The Lancet Diabetes & Endocrinology·May 29Beyond weight loss: multisystem benefits of obesity medicationsReviewObesityPaper
Diabetes, Obesity & Metabolism·May 6Clinical Characteristics of Users of Weight Loss Drugs: Population-Based Case-Control StudyCase-control study of 150,036 peoplePopulationsPaper
Preprints.org·Mar 31Toward Precision Obesity Pharmacotherapy: Using the Eating Behavior Phenotype Scale (EFCA) in Real-World Clinical PracticePreprint: cohort study of 66 peopleObesityPaper
Obesity·Mar 31Use of Naltrexone-Bupropion in Persons With Overweight/Obesity and Symptoms of Depression: A Pooled AnalysisMeta-analysis of randomized trialsNaltrexone + bupropionPaper
Obesity Pillars·Mar 20Joint TOS/OMA/OAC expert guidance statement on the pharmacological management of United States adults with overweight or obesity using the GRADE approachReviewIndustry & policyPaper
Obesity·Mar 5Joint TOS/OMA/OAC Expert Guidance Statement on the Pharmacological Management of United States Adults With Overweight or Obesity Using the GRADE ApproachReviewIndustry & policyPaper
medRxiv·Feb 27Secondary Prevention of Cardiovascular Events in Patients with Overweight/Obesity in Routine Clinical PracticePreprint: cohort study of 35,240 peopleOverweightPaper
International Journal of Clinical Pharmacy·Feb 25Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting SystemStudy of 78,000 peopleInterventionsPaper
Therapeutic Advances in Psychopharmacology·Feb 23Comparative efficacy and safety of liraglutide versus metformin, naltrexone/bupropion, and phentermine-topiramate in psychiatric patientsCohort study of 117 peopleLiraglutidePaper
Obesity·Feb 18Efficacy of Oral Antiobesity Medications With Versus Without Adjunct Behavioral Weight Management TreatmentRandomized trial in 101 peopleInterventionsPaper
Drugs & Therapy Perspectives·Feb 6Take a personalised approach to weight management for older adults with obesityReviewObesityPaper
medRxiv·Feb 4CLINICAL CHARACTERISTICS OF USERS OF WEIGHT LOSS DRUGS: POPULATION-BASED CASE-CONTROL STUDYPreprint: case-control study of 150,036 peoplePopulationsPaper
Cureus·Feb 4Glucagon-Like Peptide-1 Receptor Agonists as a Non-surgical Alternative to Bariatric Surgery for Weight Loss: A ReviewSystematic reviewGLP-1 receptor agonistsPaper
Drugs·Jan 31Pharmacological Management of Obesity in Pregnancy: A Review of Current and Emerging TherapiesSystematic review of studies in peopleObesityPaper
Current Atherosclerosis Reports·Jan 22A Review of First-Generation Obesity MedicationsReviewObesityPaper
Obesity Reviews·Jan 20Efficacy of Weight-Lowering Agents on Fat Distribution: A Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsMeta-analysis of randomized trialsInterventionsPaper
Obesity Pillars·Jan 19Outcomes of obesity medications in those with low response to a low-energy diet meal replacement programme: An observational studyCohort study of 85 peopleObesityPaper
International Journal of Obesity·Jan 5Mental health outcomes in obesity interventions with GLP-1 receptor agonists: is it similar to other obesity interventions? A narrative review with systematic evidence synthesisSystematic reviewGLP-1 receptor agonistsPaper
Ophthalmology Retina·Dec 27Rate of Age-Related Macular Degeneration in Patients Prescribed Glucagon-Like Peptide-1 Receptor Agonists or Other Weight Loss TherapiesCohort study of 60,336 peopleAge-related macular degenerationPaper
Current Opinion in Pharmacology·Nov 19From one-size-fits-all to phenotype-based pharmacotherapy: How far are we in obesity management?ReviewObesityPaper